Khaleej Times 2014.08.31 15:38
(AFP) / 31 August 2014
Cardiovascular failure, in which the heart does not pump blood effectively,
kills at least 26 million people a year worldwide.
Logo of Novartis.- AP file photo
Washington: An experimental drug from Swiss pharma giant Novartis reduced
deaths from chronic heart failure by 20 per cent compared with an existing
treatment, according to the results of a vast new study.
The new drug, called LCZ696, has been labelled a potential "blockbuster"
HEART, DRUG, CARDIOLOGY, FAILURE, HOSPITALIZATION, MEDICINE, USA, Швейцария, India, Испания